Monitoring the response to anti-rejection therapy with serum neopterin.
Smillie
A E
AE
Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Rigby
R J
RJ
Petrie
J J
JJ
D001379:Azathioprine / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood*; D001708:Biopterins / Q000031:analogs & derivatives* / Q000097:blood; D003404:Creatinine / Q000097:blood; D003524:Cyclosporins / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006084:Graft Rejection; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D016030:Kidney Transplantation; D008991:Monitoring, Physiologic; D019798:Neopterin; D011239:Prednisolone / Q000627:therapeutic use*; D012016:Reference Values; D012189:Retrospective Studies; D014184:Transplantation, Homologous
D015415:Biomarkers; D003524:Cyclosporins; D001708:Biopterins; D019798:Neopterin; D011239:Prednisolone; D003404:Creatinine; D001379:Azathioprine